Dr. Shabana Anjum, she received the B.Sc. and M.Sc. degree in Zoology from Banaras Hindu University, Varanasi (India) in 2006 and 2008, respectively. She received her Ph.D. degree in “Animal physiology and molecular mechanism of Endocrinology in male mouse ” from Banaras Hindu University, Varanasi (India) in 2016.<br /> In 2017, she joined as National Postdoctoral Fellow awarded by Science and Engineering Reseacrh Board, Department of Science technology at CSIR- Indian Institute of toxicology Research, Lucknow (India). In 2020, she joined ‘Diabetic Research Group” as a Senior Research Associate at Sharjah Institute of Medical Research, University of Sharjah UAE, and co-supervising numerous masters research projects and PhD projects within the group. In 2021, she joined “Drug Delivery Group” as a Visiting Scholar at American University of Sharjah UAE. In 2023, She joined and working as Post Doctoral Research Associate at American University of Sharjah, UAE. She was the recipient of ISSN International Research Awards in 2021 and Prof. N.J.Chinoy Award in 2012. She has the membership of World Research Council. She has a strong experience in animal physiology specially in Endocrinology and Metabolism disorder (Obesity model), Neuro degenerative (Alzheimer model), Diabetes and Cancer research with a therapeutic expertise involving mice model system. She has extensive knowledge of gene biology including next generation sequencing. She is expert in development of novel small molecules for their anti- diabetic and anti-cancer and anti-neurodegenrative activities, translational research, mechanism of drug/chemical action and understanding the molecular phenomenon and signaling pathways that are consequences of types of diabetes (type I and II), cancer and Alzheimer (both in vitro and in vivo), and other abnormalities in order to find out potential therapeutic targets. Her current research interest is focused on developing ultrasound activated targeted nanocarriers (Dox-Liposome) as well as gene therapy used for drug delivery system in multiple cancer treatment using xenograft mice models. Dr. Anjum has published outstanding number of research papers and chapters and conference proceeding in high impact journals.